The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The global esophageal cancer market is expected to grow from $1.13 billion in 2022 to $1.25 billion in 2023 at a compound annual growth rate (CAGR) of 10.3%. The esophageal cancer market is expected to reach $1.77 billion in 2027 at a CAGR of 9.10%.

North America held the largest esophageal cancer market share, and Asia Pacific was the fastest-growing region in 2022.

Esophageal Cancer Market Driver
An increase in esophageal cancer is expected to propel the esophageal cancer market growth. Esophageal cancer is a malignancy that affects the esophagus, the tube-like structure connecting the throat to the stomach. As the incidence of esophageal cancer increases, there will be a higher demand for diagnostic procedures, such as endoscopy, imaging tests, and biopsies, to detect and confirm the presence of the disease. For instance, in February 2023, according to the National Library of Medicine, a US-based medical library operated by the American government, the incidence rate of esophageal adenocarcinoma among individuals aged 40–65 is projected to rise from 2.12 per 100,000 persons in 2021 to 3.86 per 100,000 persons in 2040. This represents an 82% increase over 19 years, equivalent to a yearly growth rate of 3.2%. Therefore, the increase in esophageal cancer is expected to drive the growth of the esophageal cancer market.

View More On The Esophageal Cancer Market Report 2023 – https://www.thebusinessresearchcompany.com/report/esophageal-cancer-global-market-report

Prominent Esophageal Cancer Market Trend
New drug approval is a key trend gaining popularity in the esophageal cancer market. Major companies operating in the esophageal cancer market are focused on obtaining new drug approvals to strengthen their position and gain a competitive advantage. For instance, in May 2022, Bristol Myers Squibb, a US-based pharmaceutical company, received U.S. Food and Drug Administration (FDA) approval for its two products, including Opdivo (nivolumab) (injection for intravenous use) and Opdivo plus Yervoy (ipilimumab). Its primary therapeutic approaches are for individuals diagnosed with advanced or metastatic esophageal squamous cell carcinoma (ESCC). The authorization was granted following the Phase 3 clinical trial evaluation, which demonstrated enhanced overall survival rates among patients who received these medications.

Esophageal Cancer Market Prominent Players
Major players in the esophageal cancer market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc, AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Servier Pharmaceuticals, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Ipsen SA, Dr. Reddy’s Laboratories Ltd., Seagen Inc., Exelixis Inc., BeiGene Ltd., Clovis Oncology Inc., and Aslan Pharmaceuticals Ltd.

Request A Sample Of The Global Esophageal Cancer Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12637&type=smp

Key Esophageal Cancer Market Segments
The global esophageal cancer market is segmented –
1) By Type: Esophageal Squamous-Cell Carcinoma, Esophageal Adenocarcinoma, Other Types
2) By Treatment Type: Chemotherapy, Targeted Therapy, Other Treatment Types
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End Users: Hospitals, Homecare, Specialty Centers, Other End Users

The Esophageal Cancer Global Market Report 2023  provides a comprehensive overview on the esophageal cancer market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the esophageal cancer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Cancer Biologics Global Market Report 2023
Cancer Diagnostics Global Market Report 2023
Bone Growth Stimulator Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model